Metraipolis › archive › dc_80a92db4338e
Identification of targets of clinical FOXA1 mutants involved in EMT and immune suppression in prostate cancer — Europe PMC PMID:42337092
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42337092
- DOI
- 10.1038/s42003-[numero omesso]-2
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-31T09:16:35.957Z
- SHA-256 of the archived text
a08db0c8532b4d5cd480a5c76dbb922cb046c4959679b751bc5e45265dd0afc6- Stable URL of this page
https://metraipolis.com/documento/dc_80a92db4338e
How to cite
Identification of targets of clinical FOXA1 mutants involved in EMT and immune suppression in prostate cancer — Europe PMC PMID:42337092 — Europe PMC (en), https://europepmc.org/article/MED/42337092 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_80a92db4338e (Metraipolis archive dc_80a92db4338e, sha256 a08db0c8532b4d5cd480a5c76dbb922cb046c4959679b751bc5e45265dd0afc6)
BibTeX
@misc{dc80a92db4338e,
title = {Identification of targets of clinical FOXA1 mutants involved in EMT and immune suppression in prostate cancer — Europe PMC PMID:42337092},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42337092},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_80a92db4338e; sha256 a08db0c8532b4d5cd480a5c76dbb922cb046c4959679b751bc5e45265dd0afc6},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42337092. Agents can read the archived copy with the MCP tool read_document.